Vaderis is a science-driven, patient-focused biotech with a singular aim: to be the first to bring breakthrough therapies to people with HHT and other rare vascular diseases. Our work is guided by deep biological insight, a relentless commitment to rigorous science, impeccable execution and an unwavering belief that meaningful change is possible. We advance with purpose, inspired by the patients who drive us forward and by the promise of what has yet to be achieved. Pioneering care for people with unmet needs.
OUR STORY
Our work begins with a simple belief: deep biological insight, paired with rigorous and thoughtful science, can lead to targeted therapies that make a meaningful difference in people’s lives.
“We are tackling something that has not been done before. It is scientifically challenging, but the opportunity to make a difference within a few short years is what drives us.”
Azmi Nabulsi
President & CEO, Vaderis Therapeutics
